TitleGM - IT
DateFebruary 26, 2018
Australia’s top companies are more than halfway through reporting season, and so far those exceeding analyst expectations outnumber those that don’t.
Of the 170 ASX 200 companies due to report in February, around 130 have already announced their results, and exceeding or missing expected performance is having a direct impact on share prices. As the chart below shows, around 35% of results have exceeded expectations (meaning they were at least 5% higher than analysts estimated), while 29% have missed. Around 35% have been in line with the market’s expectations.
Resource giant BHP (BHP) reported earnings slightly below expectations, missing estimates by -6% despite a 25% rise in net profit, while Rio Tinto’s (RIO) 90% jump in earnings delivered more or less in line with expectations. Major upside surprises came from biotech giant CSL (CSL), which delivered +30% on expectations, A2 Milk Co (A2M), which beat estimates by +24%, and Insurance Australia Group (IAG), which beat estimates by +18%.
As the chart below shows, it is the upside or downside surprise that has the real impact on share prices. Over the reporting period so far, companies that have reported above-consensus earnings have seen their share price rise by 2.9% on average, while those that have missed have fallen by 3.4%.
IMPORTANT NOTICE: This document is published by Lonsec Research Pty Ltd ABN 11 151 658 561, AFSL 421 445 (Lonsec).
Please read the following before making any investment decision about any financial product mentioned in this document.
Warnings: Lonsec reserves the right to withdraw this document at any time and assumes no obligation to update this document after the date of publication. Past performance is not a reliable indicator of future performance. Any express or implied recommendation, rating, or advice presented in this document is a “class service” (as defined in the Financial Advisers Act 2008 (NZ)) or limited to “general advice” (as defined in the Corporations Act (C’th)) and based solely on consideration of data or the investment merits of the financial product(s) alone, without taking into account the investment objectives, financial situation and particular needs (“financial circumstances”) of any particular person.
Warnings and Disclosure in relation to particular products: If our general advice relates to the acquisition or possible acquisition or disposal or possible disposal of particular classes of assets or financial product(s), before making any decision the reader should obtain and consider more information, including the Investment Statement or Product Disclosure Statement and, where relevant, refer to Lonsec’s full research report for each financial product, including the disclosure notice. The reader must also consider whether it is personally appropriate in light of his or her financial circumstances or should seek further advice on its appropriateness. It is not a “personalised service” (as defined in the Financial Advisers Act 2008 (NZ)) and does not constitute a recommendation to purchase, hold, redeem or sell any financial product(s), and the reader should seek independent financial advice before investing in any financial product. Lonsec may receive a fee from Fund Manager or Product Issuer (s) for reviewing and rating individual financial product(s), using comprehensive and objective criteria. Lonsec may also receive fees from the Fund Manager or Financial Product Issuer (s) for subscribing to investment research content and services provided by Lonsec.
Disclaimer: This document is for the exclusive use of the person to whom it is provided by Lonsec and must not be used or relied upon by any other person. No representation, warranty or undertaking is given or made in relation to the accuracy or completeness of the information presented in this document, which is drawn from public information not verified by Lonsec. Conclusions, ratings and advice are reasonably held at the time of completion but subject to change without notice. Lonsec assumes no obligation to update this document following publication. Except for any liability which cannot be excluded, Lonsec, its directors, officers, employees and agents disclaim all liability for any error, inaccuracy, misstatement or omission, or any loss suffered through relying on the information.
03 9623 6373
15 Nov 2018 - Leading research and investment solutions house Lonsec has appointed Rob Hardy to the newly created role of Executive Director of Sales and Marketing. Mr ...
15 Nov 2018 - Financial advisers are now able to access investment research, encompassing clients’ whole of life needs, with the announcement by Lonsec of the inclusion of ...
12 Sep 2018 - Exchange Traded Funds (ETFs) have become a popular way for investors to gain exposure not only to passive indices but to a range of market factors. Smart ...